Status:
WITHDRAWN
Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne
Lead Sponsor:
Allergan
Conditions:
Acne Vulgaris
Eligibility:
All Genders
18-64 years
Phase:
PHASE1
Brief Summary
This study will investigate the pharmacokinetics, safety and tolerability of dapsone and adapalene following topical administration of 2 formulations of dapsone/adapalene fixed combination gel, dapson...
Eligibility Criteria
Inclusion
- Moderate acne on the face
- Willing to avoid swimming during the study
- Willing to avoid excessive sunlight and ultraviolet light (e.g., tanning beds)during the study
- Willing to avoid moisturizers, sunscreens, cosmetics, and chemical peels during the study
Exclusion
- Severe cystic acne
- Use of topical or oral retinoids within 4 weeks
- Use of isotretinoin within 3 months
- Use of dapsone or adapalene within 3 months
- Anticipated need to engage in activities/exercise that would cause profuse sweating
- Donated blood or equivalent blood loss within 90 days
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01425320
Start Date
January 1 2013
End Date
June 1 2013
Last Update
November 19 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.